Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07513311 · ClinicalTrials.gov registry record · NA
A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT07513311: Recruiting NA study, sponsored by Massachusetts General Hospital.
NCT07513311 is a NA study that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07513311, a NA study, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the feasibility and acceptability of a nurse-led, coping, and supportive care intervention for patients with triple-negative breast cancer. The intervention aims to improve psychosocial outcomes in patients with triple-negative breast cancer (e.g., quality of life (QOL), anxiety, fear of cancer recurrence (FCR)).
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL RESTORE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07513311
The ClinicalTrials.gov registry entry for NCT07513311 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT07513311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07513311 about?
NCT07513311 is a clinical study titled "A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer". The purpose of this study is to explore the feasibility and acceptability of a nurse-led, coping, and supportive care intervention for patients with triple-negative breast cancer. The intervention aims to improve psychosocial outcomes in patients with triple-negative breast cancer (e.g., quality of ...
What is the current status of trial NCT07513311?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-06. Estimated completion is 2028-07-31.
What interventions are being tested in trial NCT07513311?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), RESTORE (BEHAVIORAL).
Who is sponsoring clinical trial NCT07513311?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.